All filters
Abstracts
Changes in drug interaction profiles for first-line HIV therapy over the 20 years of the Liverpool Drug Interaction website.
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
The initial Phase 1 evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next generation HIV maturation inhibitor, as assessed in healthy subjects
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Population pharmacokinetics of VRC01 in infants and adults
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
In silico design of a microarray patch as a multipurpose prevention technology
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Efavirenz pharmacokinetics in HIV/TB coinfected persons initiating ART while receiving high dose rifapentine
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Managing Complex Patients - US | Gandhi
Presented at:
Managing Complex HIV Patients 2020- US Edition
Slidesets
Managing Complex Patients - US | Flexner
Presented at:
Managing Complex HIV Patients 2020- US Edition
Slidesets
Managing Complex Patients - US | Walmsley
Presented at:
Managing Complex HIV Patients 2020- US Edition
Slidesets
Managing Complex Patients - US | Kuritzkes
Presented at:
Managing Complex HIV Patients 2020- US Edition
Slidesets
Managing Complex Patients - US | Kozal
Presented at:
Managing Complex HIV Patients 2020- US Edition
Slidesets
FIND - Claude Mambo Muvunyi
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_40_Possible Role of Natural Killer Cells in Hepatitis C Virus Related Hepatocellular Carcinoma
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_39_Outcomes of Sorafenib therapy for hepatocellular carcinoma in Ethiopia
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_41_Risks of developing hepatocellular carcinoma in patients with chronic HCV-infection
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_42_Hepatic Resection for Hepatocelullar Carcinoma in Nigeria: a Sigle Centre Experiece from Northwest Nigeria
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_43_Plasminogen Activator Inhibitor Type 1 in Liver Cirrhosis Patients and Non-Alcoholic Steatohepatitis under the Influence of Treatment with Human Albumin Infusion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_44_Clinical and laboratory predictors of mortality in patients hospitalized for liver cirrhosis in Cameroon
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_45_Devenir au long cours des patients traités par analogues nucléot(s)idiques pour cirrhose virale B à l’Hôpital Principal de Dakar
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_46_Correction of portohepatic hemodynamics disorders and increased ammonia by ornithine at the non-alcoholic steatohepatitis patients without cirrhosis
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_47_Impact of Treating Hyperuricemic NAFLD Patients with Allopurinol on Cytokeratin 18: A Pilot Study
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_48_IL-23 and MMP-9 as predictors of adverse course of psoriasis and NAFLD comorbidities
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_49_Les hépatites auto-immunes à l’Hôpital Principal de Dakar : étude rétrospective à propos de 19 cas.
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020